Your browser doesn't support javascript.
loading
Ablative Radiation Therapy to Restrain Everything Safely Treatable (ARREST): A Phase 1 Study of Stereotactic Ablative Radiation Therapy for Polymetastatic Disease.
Nguyen, Timothy K; Ramadan, Sherif; Palma, David A; Corkum, Mark T; O' Neil, Melissa; Celinski, Anders; Fakir, Hatim; Warner, Andrew; Hallock, Abhirami; Correa, Rohann J M; Qu, X Melody; Lock, Michael; Lang, Pencilla; Velker, Vikram; Bauman, Glenn S.
Affiliation
  • Nguyen TK; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Ramadan S; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Palma DA; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Corkum MT; Division of Radiation Oncology, Department of Radiology, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • O' Neil M; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Celinski A; Department of Medical Biophysics, Western University, London, Ontario, Canada.
  • Fakir H; Department of Medical Biophysics, Western University, London, Ontario, Canada.
  • Warner A; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Hallock A; Department of Radiation Oncology, Niagara Health, St. Catherine's, Ontario, Canada.
  • Correa RJM; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Qu XM; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Lock M; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Lang P; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Velker V; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Bauman GS; Division of Radiation Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada. Electronic address: Glenn.Bauman@lhsc.on.ca.
Article in En | MEDLINE | ID: mdl-38986914

Full text: 1 Database: MEDLINE Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2024 Type: Article Affiliation country: Canada

Full text: 1 Database: MEDLINE Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2024 Type: Article Affiliation country: Canada